Omni Ophthalmic Management Consultants

Omni Ophthalmic Management Consultants specializes in comprehensive vision care, providing medical, surgical, and cosmetic solutions for various eye conditions, utilizing advanced technology and tailored patient care strategies. Founded in 1986 and headquartered in Iselin, US, Omni Ophthalmic Management Consultants operates under the Omni Eye Medical Center (OOMC) brand. The company primarily focuses on delivering specialized ophthalmic care and expanded its offerings over the years, including advanced surgical solutions. The management team includes CEOs Andrew Murray and Christopher Quinn.

OOMC has completed 1 deal, with the most recent deal occurring on July 6, 2017. Ophthalmology Specialists operating under the Omni Eye Medical Center (OOMC) brand provide a comprehensive suite of medical, surgical, and cosmetic vision care services aimed at addressing a variety of eye conditions. The core offerings include treatments for cataracts, glaucoma, diabetic retinopathy, and macular degeneration, as well as advanced surgical solutions such as LASIK and EVO ICL™. OOMC serves a diverse client base, including patients with chronic eye diseases and those seeking corrective vision procedures, in geographical markets extending beyond Iselin, NJ, to broader areas within New Jersey and Pennsylvania, and parts of neighboring states, emphasizing collaborative partnerships with optometrists and healthcare providers to ensure comprehensive patient care.

OOMC's revenue generation model is structured around direct-to-consumer services and collaborations with referring healthcare providers, engaging primarily through consultations, surgical procedures, and ancillary services. Notable flagship services include LASIK surgeries and advanced treatments for eye diseases, billed on a per-procedure basis. Partnerships with optometrists facilitate a steady flow of patient referrals, enhancing OOMC's market reach. The firm also implements financing options for patients requiring extensive vision correction procedures.

With the most recent deal occurring on July 6, 2017, Omni Ophthalmic Management Consultants is focusing on expanding its product offerings and market reach. The company plans to introduce new ophthalmic technologies and services tailored to patient needs. Specific geographic expansions are being considered in New Jersey and Pennsylvania, aiming to enhance service accessibility by the end of 2023. Recent investment support from New MainStream Capital and management will be allocated towards these growth initiatives.